Wedge Capital Management’s Thermo Fisher Scientific TMO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $7.24M | Buy |
17,847
+10,381
| +139% | +$4.21M | 0.13% | 169 |
|
|
2025
Q1 | $3.72M | Buy |
7,466
+6,760
| +958% | +$3.36M | 0.07% | 227 |
|
|
2024
Q4 | $367K | Buy |
706
+28
| +4% | +$14.6K | 0.01% | 481 |
|
|
2024
Q3 | $419K | Buy |
678
+14
| +2% | +$8.66K | 0.01% | 469 |
|
|
2024
Q2 | $367K | Sell |
664
-78
| -11% | -$43.1K | 0.01% | 460 |
|
|
2024
Q1 | $431K | Buy |
742
+7
| +1% | +$4.07K | 0.01% | 460 |
|
|
2023
Q4 | $390K | Sell |
735
-5
| -0.7% | -$2.65K | 0.01% | 453 |
|
|
2023
Q3 | $375K | Buy |
740
+57
| +8% | +$28.9K | 0.01% | 453 |
|
|
2023
Q2 | $356K | Sell |
683
-17
| -2% | -$8.87K | 0.01% | 483 |
|
|
2023
Q1 | $403K | Sell |
700
-3
| -0.4% | -$1.73K | 0.01% | 330 |
|
|
2022
Q4 | $387K | Buy |
703
+9
| +1% | +$4.95K | 0.01% | 329 |
|
|
2022
Q3 | $352K | Sell |
694
-22
| -3% | -$11.2K | 0.01% | 330 |
|
|
2022
Q2 | $389K | Hold |
716
| – | – | 0.01% | 327 |
|
|
2022
Q1 | $423K | Sell |
716
-17
| -2% | -$10K | 0.01% | 323 |
|
|
2021
Q4 | $489K | Buy |
733
+15
| +2% | +$10K | 0.01% | 321 |
|
|
2021
Q3 | $410K | Sell |
718
-20
| -3% | -$11.4K | 0.01% | 326 |
|
|
2021
Q2 | $372K | Sell |
738
-167
| -18% | -$84.2K | ﹤0.01% | 325 |
|
|
2021
Q1 | $413K | Sell |
905
-37
| -4% | -$16.9K | ﹤0.01% | 389 |
|
|
2020
Q4 | $439K | Hold |
942
| – | – | 0.01% | 415 |
|
|
2020
Q3 | $416K | Buy |
942
+26
| +3% | +$11.5K | 0.01% | 399 |
|
|
2020
Q2 | $332K | Sell |
916
-37
| -4% | -$13.4K | ﹤0.01% | 406 |
|
|
2020
Q1 | $270K | Buy |
953
+13
| +1% | +$3.68K | ﹤0.01% | 419 |
|
|
2019
Q4 | $305K | Buy |
940
+16
| +2% | +$5.19K | ﹤0.01% | 472 |
|
|
2019
Q3 | $269K | Sell |
924
-11
| -1% | -$3.2K | ﹤0.01% | 496 |
|
|
2019
Q2 | $275K | Buy |
+935
| New | +$275K | ﹤0.01% | 542 |
|